Search

everythinglearnresearchcommunity

for

Search:↓

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

FDG PET/CT scans can change cancer treatment plans for dogs.

Cancer cells often have more copies of TERT and TERC genes, which helps them grow and could affect patient outcomes.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

The document concludes that various skin conditions have specific treatments, ranging from antihistamines for urticaria to surgery and medication for tumors and chronic skin diseases.

The European School of Oncology organized various educational events in 1994, highlighting important cancer research findings.

Targeting the Smoothened receptor shows promise for treating certain cancers.

New therapies are being developed that target integrin pathways to treat various diseases.

Kang-ai injection with platinum-based chemotherapy improves tumor response and immune function while reducing side effects in advanced lung cancer.

Combining specific nanoparticles with immune therapy significantly improves cancer treatment.

Hedgehog pathway inhibitors can treat certain aggressive cancers but face limitations like resistance and side effects.

A woman with hair loss had a benign sweat duct tumor found during a scalp biopsy.

RNA aptamers can specifically block FGF5-related cell growth, potentially treating related diseases or hair disorders.

Macrophages help regrow hair by activating stem cells using AKT/β-catenin and TNF.

Keratins help protect cells, aid in cancer diagnosis, and influence cancer behavior and treatment.

DHT affects hair follicle cells by changing microRNA levels, leading to less cell growth and more cell death.

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

Green tea extract helps prevent cell death and supports cell survival in hair cells exposed to a chemotherapy drug.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

ePUKs could be valuable for regenerative medicine due to their wound healing abilities.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

Significant progress and collaborations in stem cell research and regenerative medicine were made, including advancements in hair growth, cancer therapies, and treatments for neurological disorders.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

Hair follicle hyperplasia is common in both benign and malignant skin lymphoproliferative disorders, with a proposed new term "pseudolymphomatous adnexitis."

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

Bone marrow stem cells and their medium help hair regrowth.

The document concluded that stem cells are crucial for skin repair, regeneration, and may help in developing advanced skin substitutes.

Understanding phenotypic plasticity is crucial for developing effective cancer therapies.